Super Generics Market is segmented By Therapeutic Area (Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncological Disorders, ....
Market Size in USD
CAGR8.3%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 8.3% |
Market Concentration | High |
Major Players | Accord Healthcare, Alcon Laboratories, Azurity Pharmaceuticals, Baxter, Dr. Reddy’s Laboratories |
The super generics market is estimated to be valued at USD 84 Bn in 2024 and is expected to reach USD 200 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8.3% from 2024 to 2031.
The super generics market is expected to witness positive growth trends during the forecast period. Factors such as increasing demand for low-cost drugs, growing prevalence of chronic diseases and rising geriatric population worldwide are expected to drive the demand for super generic drugs. Additionally, patent expiries of blockbuster drugs provide significant opportunities for investments and entry of new players in the super generics market space. However, pricing pressure due to intense competition among existing players may moderately impact the growth of this market to some extent. stringency of regulatory framework.